Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$155.22 - $162.74 $271,014 - $284,144
1,746 New
1,746 $276,000
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $34,888 - $39,083
-224 Reduced 11.31%
1,756 $273,000
Q2 2023

Aug 01, 2023

BUY
$154.35 - $166.11 $51,861 - $55,812
336 Added 20.44%
1,980 $327,000
Q1 2023

May 03, 2023

SELL
$151.05 - $180.26 $127,788 - $152,499
-846 Reduced 33.98%
1,644 $254,000
Q4 2022

Jan 27, 2023

BUY
$160.2 - $179.79 $20,986 - $23,552
131 Added 5.55%
2,490 $0
Q3 2022

Oct 21, 2022

BUY
$161.33 - $179.52 $158,748 - $176,647
984 Added 71.56%
2,359 $385,000
Q2 2022

Aug 03, 2022

BUY
$168.19 - $186.01 $37,506 - $41,480
223 Added 19.36%
1,375 $244,000
Q1 2022

May 03, 2022

BUY
$158.14 - $179.59 $182,177 - $206,887
1,152 New
1,152 $205,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Motive Wealth Advisors Portfolio

Follow Motive Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Motive Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Motive Wealth Advisors with notifications on news.